NO170753C - Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering - Google Patents

Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering

Info

Publication number: NO170753C
Authority: NO; Norway
Prior art keywords: pharmaceutically acceptable; compound; oral compositions; compositions; range
Prior art date: 1983-07-07

Application number

NO842766A

Other languages

English (en)

Norwegian (no)

Other versions

NO170753B (no

NO842766L (no

Inventor

David R Powell

Vithal K Patel

Original Assignee

Rowell Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-07-07

Filing date

1984-07-06

Publication date

1992-12-02

1984-07-06 Application filed by Rowell Lab Inc filed Critical Rowell Lab Inc

1985-01-08 Publication of NO842766L publication Critical patent/NO842766L/no

1992-08-24 Publication of NO170753B publication Critical patent/NO170753B/no

1992-12-02 Publication of NO170753C publication Critical patent/NO170753C/no

Links

239000007787 solid Substances 0.000 title abstract 2
230000003111 delayed effect Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
239000000203 mixture Substances 0.000 abstract 7
150000001875 compounds Chemical class 0.000 abstract 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
239000004480 active ingredient Substances 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000011230 binding agent Substances 0.000 abstract 1
230000003628 erosive effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000004094 surface-active agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Electroplating Methods And Accessories (AREA)
Mechanical Treatment Of Semiconductor (AREA)
Sliding Valves (AREA)

NO842766A 1983-07-07 1984-07-06 Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering NO170753C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/511,605 US4539198A (en)	1983-07-07	1983-07-07	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range

Publications (3)

Publication Number	Publication Date
NO842766L NO842766L (no)	1985-01-08
NO170753B NO170753B (no)	1992-08-24
NO170753C true NO170753C (no)	1992-12-02

Family

ID=24035636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO842766A NO170753C (no)	1983-07-07	1984-07-06	Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering

Country Status (14)

Country	Link
US (1)	US4539198A (fr)
EP (1)	EP0131485B1 (fr)
AT (1)	ATE55900T1 (fr)
AU (1)	AU561633B2 (fr)
CA (1)	CA1224417A (fr)
DE (1)	DE3483072D1 (fr)
DK (1)	DK162697C (fr)
ES (1)	ES8600053A1 (fr)
FI (1)	FI842528A7 (fr)
IL (1)	IL72089A (fr)
IT (1)	IT1180193B (fr)
NO (1)	NO170753C (fr)
NZ (1)	NZ208393A (fr)
ZA (1)	ZA845208B (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4960765A (en) *	1980-03-20	1990-10-02	Farmaceutisk Laboratorium Ferring A/S	Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1981002671A1 (fr) *	1980-03-20	1981-10-01	Ferring Farma Lab	Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
US4690824A (en) *	1983-07-07	1987-09-01	Redi-Rowell, Inc.	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
GB8322007D0 (en) *	1983-08-16	1983-09-21	Wellcome Found	Pharmaceutical delivery system
USRE33994E (en) *	1983-08-16	1992-07-14	Burroughs Wellcome Co.	Pharmaceutical delivery system
US4751071A (en) *	1983-12-01	1988-06-14	Alza Corporation	Composition comprising salbutamol
US4777049A (en) *	1983-12-01	1988-10-11	Alza Corporation	Constant release system with pulsed release
US4851229A (en) *	1983-12-01	1989-07-25	Alza Corporation	Composition comprising a therapeutic agent and a modulating agent
DE3346571A1 (de) *	1983-12-23	1985-07-04	Bayer Ag, 5090 Leverkusen	Oral retardierte acetylsalicylsaeureformulierungen
IT1206166B (it) *	1984-07-26	1989-04-14	Sigma Tau Ind Farmaceuti	Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4631305A (en) *	1985-03-22	1986-12-23	The Upjohn Company	Polymeric material as a disintegrant in a compressed tablet
JPH0830005B2 (ja) *	1985-09-25	1996-03-27	ゲルゲリイ、ゲルハルト	崩壊性錠剤とその製造方法
US4753801A (en) *	1985-10-25	1988-06-28	Eli Lilly And Company	Sustained release tablets
AU607690B2 (en) *	1985-12-24	1991-03-14	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
US6482516B1 (en) *	1993-07-20	2002-11-19	Banner Pharmacaps, Inc.	Enrobed tablet
MX9300110A (es) *	1992-01-13	1994-07-29	Gerhard Gergely	Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en)	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5609883A (en) *	1994-09-16	1997-03-11	Advanced Technology Pharmaceuticals Corporation	Compressed tablet transitory lubricant system
HUP0104606A3 (en) *	1998-12-18	2003-01-28	Basf Ag	A pharmaceutical mixture comprising a profen
US6726929B1 (en)	1998-12-18	2004-04-27	Basf Aktiengesellschaft	Pharmaceutical mixture comprising a profen
US8545880B2 (en) *	1999-02-26	2013-10-01	Andrx Pharmaceuticals, Llc	Controlled release oral dosage form
US6210716B1 (en)	1999-02-26	2001-04-03	Andrx Pharmaceuticals, Inc.	Controlled release bupropion formulation
BR0013719A (pt)	1999-09-02	2002-07-23	Nostrum Pharmaceuticals Inc	Dosagem oral de liberaçâo controlada, apropriada para administração oral
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
US9522217B2 (en)	2000-03-15	2016-12-20	Orbusneich Medical, Inc.	Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en)	2000-03-15	2012-01-03	Orbusneich Medical, Inc.	Progenitor endothelial cell capturing with a drug eluting implantable medical device
EP1642885B1 (fr)	2000-08-29	2009-11-11	Biocon Limited	Utilisation d'une composition pharmaceutique contenant un dérivé de l'acide para-aminophénylacétique dans le traitement de maladies inflammatoires des voies gastro-intestinales
CA2359812C (fr) *	2000-11-20	2004-02-10	The Procter & Gamble Company	Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
US20030032675A1 (en) *	2001-02-15	2003-02-13	Franz G. Andrew	Manufacture of thyroid hormone tablets having consistent active moiety amounts
JP2004525109A (ja) *	2001-02-15	2004-08-19	キング・ファーマシューティカルズ・インコーポレイティッド	安定化された甲状腺ホルモン医薬組成物、及びその製法
US20030224047A1 (en) *	2001-02-15	2003-12-04	Franz G. Andrew	Levothyroxine compositions and methods
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
US20030198667A1 (en) *	2001-08-10	2003-10-23	Franz Andrew G.	Methods of producing dispersible pharmaceutical compositions
US20030198671A1 (en) *	2001-08-10	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) *	2001-08-10	2003-10-09	Franz G. Andrew	Methods of stabilizing pharmaceutical compositions
US20030180353A1 (en) *	2001-08-10	2003-09-25	Franz G. Andrew	Stabilized pharmaceutical compositions
US20030198672A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030203967A1 (en) *	2001-08-14	2003-10-30	Franz G. Andrew	Levothyroxine compositions having unique Tmax properties
US20030195253A1 (en) *	2001-08-14	2003-10-16	Franz G. Andrew	Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030199587A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique Cmax properties
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
US20030199586A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Unique levothyroxine aqueous materials
US8048924B2 (en)	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
US20040043066A1 (en) *	2001-10-29	2004-03-04	Franz G. Andrew	Levothyroxine compositions having unique triiodothyronine Tmax properties
US6893660B2 (en) *	2002-11-21	2005-05-17	Andrx Pharmaceuticals, Inc.	Stable pharmaceutical compositions without a stabilizer
NZ551836A (en)	2004-07-02	2008-07-31	Meiji Dairies Corp	Solid milk and method of producing the same
HUE028158T2 (en)	2004-07-07	2016-12-28	Biocon Ltd	Synthesis of bound immunoregulatory compounds
BRPI0514827A (pt) *	2004-09-01	2008-06-24	Procter & Gamble	composições compreendendo ácido 5-amino-2hidróxi- benzóico e açúcar redutor
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
WO2007027566A2 (fr)	2005-09-02	2007-03-08	Genzyme Corporation	Recepteurs moleculaires polymeriques utilises comme sequestrants du phosphate
CA2622693C (fr)	2005-09-15	2015-05-05	Genzyme Corporation	Formulation en sachet pour des polymeres amines
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20080075785A1 (en) *	2006-09-22	2008-03-27	San-Laung Chow	Controlled release hydrogel formulation
US20110165236A1 (en) *	2006-09-22	2011-07-07	Biokey, Inc.	Controlled release hydrogel formulation
EP2066293A2 (fr)	2006-09-29	2009-06-10	Genzyme Corporation	Compositions dendrimères d'amide
US8163799B2 (en)	2006-12-14	2012-04-24	Genzyme Corporation	Amido-amine polymer compositions
US20090036414A1 (en) *	2007-08-02	2009-02-05	Mutual Pharmaceutical Company, Inc.	Mesalamine Formulations
HUE038452T2 (hu)	2007-11-13	2018-10-29	Meritage Pharma Inc	Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók
EP2217215A1 (fr) *	2007-12-14	2010-08-18	Genzyme Corporation	Compositions pharmaceutiques enrobées
WO2010026993A1 (fr)	2008-09-03	2010-03-11	武田薬品工業株式会社	Procédé pour améliorer la capacité d'une préparation à être absorbée et préparation dont la capacité à être absorbée est améliorée
WO2010144865A2 (fr)	2009-06-12	2010-12-16	Meritage Pharma, Inc.	Procédés de traitement de troubles gastro-intestinaux
WO2011136376A1 (fr)	2010-04-30	2011-11-03	武田薬品工業株式会社	Comprimé à délitage intestinal
US8920840B2 (en)	2010-04-30	2014-12-30	Takeda Pharmaceutical Company Limited	Enteric tablet
DE102010033527A1 (de)	2010-08-05	2012-02-09	Acino Pharma Ag	Quetiapin-Tabletten
EP2425826A1 (fr)	2010-09-01	2012-03-07	Disphar International B.V.	Comprimé de mésalazine doté d'une dissolution améliorée
DE102011115690A1 (de)	2011-10-11	2013-04-11	Acino Pharma Ag	Quetiapin enthaltende Formulierungen
ITUA20162293A1 (it)	2016-04-05	2017-10-05	Sofar Spa	Processo per formulazioni solide di mesalazina
EP3662898A1 (fr) *	2018-12-07	2020-06-10	Tillotts Pharma AG	Formulation solide comprenant de la mésalamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4361545A (en) *	1979-05-21	1982-11-30	Rowell Laboratories, Inc.	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) *	1979-05-21	1981-04-28	Rowell Laboratories, Inc.	Pharmaceutical formulation for slow release via controlled surface erosion
FR2471186A1 (fr) *	1979-12-10	1981-06-19	Roussel Uclaf	Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
WO1981002671A1 (fr) *	1980-03-20	1981-10-01	Ferring Farma Lab	Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale

1983
- 1983-07-07 US US06/511,605 patent/US4539198A/en not_active Expired - Lifetime
1984
- 1984-05-28 CA CA000455307A patent/CA1224417A/fr not_active Expired
- 1984-05-31 AU AU28898/84A patent/AU561633B2/en not_active Ceased
- 1984-06-06 DE DE8484401152T patent/DE3483072D1/de not_active Expired - Fee Related
- 1984-06-06 AT AT84401152T patent/ATE55900T1/de not_active IP Right Cessation
- 1984-06-06 NZ NZ208393A patent/NZ208393A/en unknown
- 1984-06-06 EP EP84401152A patent/EP0131485B1/fr not_active Expired - Lifetime
- 1984-06-13 IL IL72089A patent/IL72089A/xx not_active IP Right Cessation
- 1984-06-21 FI FI842528A patent/FI842528A7/fi not_active Application Discontinuation
- 1984-07-02 IT IT21720/84A patent/IT1180193B/it active
- 1984-07-06 DK DK333884A patent/DK162697C/da not_active IP Right Cessation
- 1984-07-06 NO NO842766A patent/NO170753C/no not_active IP Right Cessation
- 1984-07-06 ZA ZA845208A patent/ZA845208B/xx unknown
- 1984-07-06 ES ES534096A patent/ES8600053A1/es not_active Expired

Also Published As

Publication number	Publication date
ES534096A0 (es)	1985-10-01
ES8600053A1 (es)	1985-10-01
IL72089A (en)	1987-09-16
FI842528A0 (fi)	1984-06-21
NO170753B (no)	1992-08-24
US4539198A (en)	1985-09-03
DE3483072D1 (de)	1990-10-04
NO842766L (no)	1985-01-08
AU2889884A (en)	1985-01-10
IT8421720A1 (it)	1986-01-02
EP0131485A2 (fr)	1985-01-16
AU561633B2 (en)	1987-05-14
ATE55900T1 (de)	1990-09-15
ZA845208B (en)	1985-03-27
DK162697B (da)	1991-12-02
DK333884A (da)	1985-01-08
DK162697C (da)	1992-04-21
IL72089A0 (en)	1984-10-31
NZ208393A (en)	1987-03-31
EP0131485A3 (en)	1986-08-06
FI842528A7 (fi)	1985-01-08
IT1180193B (it)	1987-09-23
CA1224417A (fr)	1987-07-21
DK333884D0 (da)	1984-07-06
EP0131485B1 (fr)	1990-08-29
IT8421720A0 (it)	1984-07-02

Legal Events

Date	Code	Title	Description
2001-03-05	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JANUARY 2001

Publication	Publication Date	Title
NO842766L (no)	1985-01-08	Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering
IL111647A (en)	1999-12-22	Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation
ES8603870A1 (es)	1986-01-01	Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
CA2103443A1 (fr)	1992-11-29	Composition a macher pour l'administration de medicaments
ES479474A1 (es)	1979-12-16	Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
EP0254067A3 (fr)	1988-09-14	Composition pour la prévention de la métastase
DK0385582T3 (da)	1992-09-14	Nifedipin-holdige farmaceutiske præparater og fremgangsmåde til fremstilling heraf
FI945081A0 (fi)	1994-10-28	Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
BG105436A (en)	2001-11-30	Pharmaceutical compositions comprising entacapone or nitecapone as well as a cross-linked cellulpse derivative
IL102814A0 (en)	1993-01-31	Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
IE894049L (en)	1990-06-22	Therapeutically active substituted benzimidazole and process¹for its preparation
FI921809A0 (fi)	1992-04-23	Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.
FI850828L (fi)	1985-09-09	Nya (8s)-8 -fluoroerytromycinderivat, foerfarande foer framstaellning av dessa och farmaceutiska sammansaettningar innehaollande dem.
CA2135179A1 (fr)	1993-11-11	Compositions pharmaceutiques d'agonistes 5ht1 de type alkylsulfonamides, pour administration rectale
ATE327742T1 (de)	2006-06-15	Zweiphasige zusammensetzung mit tramadol
JPS57200361A (en)	1982-12-08	"indomethacin(r)" pharmaceutical with low irritant action
KR910019625A (ko)	1991-12-19	뼈의 무기질 소실을 억제하는 방법
GB1354451A (en)	1974-06-05	Halogen-substituted phenyl-alkylamines and their derivatives
Kiesel et al.	1994	Prevention of diabetes in BB rats by an E. coli extract(OM-89)
DK0483320T3 (da)	1995-01-30	Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
ES342394A1 (es)	1968-09-16	Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2).
KR910002455A (ko)	1991-02-25	아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
GB1478020A (en)	1977-06-29	Composition for the treatment of asthma
TH59782A3 (th)	2003-12-04	สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม
KR960007619A (ko)	1996-03-22	신규 알긴산 유도체 및 그 제조방법